Simulations Plus, Inc. (SLP): Price and Financial Metrics


Simulations Plus, Inc. (SLP): $54.68

1.03 (+1.92%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SLP POWR Grades


  • Quality is the dimension where SLP ranks best; there it ranks ahead of 87.77% of US stocks.
  • SLP's strongest trending metric is Momentum; it's been moving down over the last 31 weeks.
  • SLP ranks lowest in Value; there it ranks in the 7th percentile.

SLP Stock Summary

  • SLP's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,240.75 -- higher than 96.33% of US-listed equities with positive expected earnings growth.
  • With a price/earnings ratio of 100.97, Simulations Plus Inc P/E ratio is greater than that of about 91.58% of stocks in our set with positive earnings.
  • Price to trailing twelve month operating cash flow for SLP is currently 79.58, higher than 94.59% of US stocks with positive operating cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Simulations Plus Inc are MASI, ICUI, AVAV, FDS, and AMCX.
  • Visit SLP's SEC page to see the company's official filings. To visit the company's web site, go to www.simulations-plus.com.

SLP Price Target

For more insight on analysts targets of SLP, see our SLP price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $84.67 Average Broker Recommendation 1.5 (Moderate Buy)

SLP Stock Price Chart Interactive Chart >

Price chart for SLP

SLP Price/Volume Stats

Current price $54.68 52-week high $90.92
Prev. close $53.65 52-week low $48.02
Day low $53.83 Volume 62,900
Day high $54.85 Avg. volume 200,708
50-day MA $58.07 Dividend yield 0.44%
200-day MA $66.22 Market Cap 1.10B

Simulations Plus, Inc. (SLP) Company Bio


Simulations Plus develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The company was founded in 1996 and is based in Lancaster, California.

SLP Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$54.68$6.21 -88%

We started the process of determining a valid price forecast for Simulations Plus Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Simulations Plus Inc ranked in the 14th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for SLP, they are:

  • SLP's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 62.9% of tickers in our DCF set.
  • Relative to other stocks in its sector (Technology), Simulations Plus Inc has a reliance on debt greater than just 3.4% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-89%
1%-89%
2%-88%
3%-88%
4%-88%
5%-88%

For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as SLP, try IIJIY, ALTR, COMM, CPSH, and MSTR.


SLP Latest News Stream


Event/Time News Detail
Loading, please wait...

SLP Latest Social Stream


Loading social stream, please wait...

View Full SLP Social Stream

Latest SLP News From Around the Web

Below are the latest news stories about Simulations Plus Inc that investors may wish to consider to help them evaluate SLP as an investment opportunity.

Simulations Plus (SLP) Presents At 16th Annual Virtual Technology & Media Virtual Conference - Slideshow

The following slide deck was published by Simulations Plus, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | June 4, 2021

Simulations Plus Uplisted to The Nasdaq Global Select Market®

Simulations Plus (SLP) announced today that its securities will be listed on The Nasdaq Global Select Market with the open of business on May 13, 2021

Yahoo | May 12, 2021

Simulations Plus: Q2 Earnings Insights

Shares of Simulations Plus (NASDAQ:SLP) moved higher after the company reported Q2 results. Quarterly Results Earnings per share increased 25.00% over the …

Benzinga | April 12, 2021

Simulations Plus, Inc.'s (NASDAQ:SLP) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simulations Plus (NASDAQ:SLP) has had a rough three months with its share price down 20%. But if you pay close...

Yahoo | April 8, 2021

Simulations Plus (SLP) to Post Q2 Earnings: What to Expect?

Simulations Plus (SLP) fiscal second-quarter results are likely to reflect gains from solid uptick in modeling and simulations workflow platform for drug development across pharma and biotech industries.

Yahoo | April 7, 2021

Read More 'SLP' Stories Here

SLP Price Returns

1-mo 5.23%
3-mo -23.70%
6-mo -8.74%
1-year 12.49%
3-year 166.24%
5-year 669.77%
YTD -23.84%
2020 148.64%
2019 47.45%
2018 25.26%
2017 69.51%
2016 -0.44%

SLP Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full SLP Dividend History

Continue Researching SLP

Here are a few links from around the web to help you further your research on Simulations Plus Inc's stock as an investment opportunity:

Simulations Plus Inc (SLP) Stock Price | Nasdaq
Simulations Plus Inc (SLP) Stock Quote, History and News - Yahoo Finance
Simulations Plus Inc (SLP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9545 seconds.